Leaders come together for the first time to advance the field of cellular medicine and its treatment of pain and function associated with knee osteoarthritis

Blog

Leaders come together for the first time to advance the field of cellular medicine and its treatment of pain and function associated with knee osteoarthritis

GID BIO completed an FDA compliant, multi-site, randomized, placebo-controlled Phase IIb clinical trial using autologous stromal cells in the treatment of knee osteoarthritis (OA), successfully meeting endpoints and two-year safety results…

Share the news using the buttons below

Signup our newsletter to get updated information, and insight about GID BIO

Latest article

GID BIO reaches halfway enrollment in randomized double-blinded pivotal Phase III cell therapy trial

GID BIO News

GID BIO welcomes director of clinical operations

GID BIO News

Dr. Manish Gupta joins the GIDOA-3 team

GID BIO News

The FDA approval process is important for patient safety and cell therapy research

GID BIO News

FDA announces consolidation of regulatory oversight responsibilities for fat transfer devices that process adipose tissue for return to the body

GID BIO News

Two new employees join GID BIO team

GID BIO News

Beyond drugs and surgery: changing medicine as we know it

Developing the emerging field of cellular therapy.

Company

About GID BIO

The GID BIO Team

Contact Us

FAQs

Blog

Leaders come together for the first time to advance the field of cellular medicine and its treatment of pain and function associated with knee osteoarthritis

Share the news using the buttons below

Newsletter

Latest article

Beyond drugs and surgery: changing medicine as we know it

Company

Contact Us

Newsletter